Improvement of renal function prior to liver transplantation is not associated with better long-term renal outcome or survival Thomas Horvatits; Peter Hübener; Marcel Touma; Karoline Horvatits; Lutz Fischer; Ansgar W. Lohse; Martina Sterneck;

Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab Lorenz Kocheise; Jan Kempski; Yunhe Tang; Lorenz Balcar; Victoria Berger; Miriam Tomczak; Joao Gorgulho; Ramsha Masood; Franziska Giehren; Constantin Schmidt; Jan P. Sutter; Thorben W. Fruendt; Francesca Pagani; Sophie Wulf; Julian Kött; Saskia Domanig; Anastasios Giannou; Tanja Bedke; Jöran Lücke; Tao Zhang; Siwen Zhang; Andres Machicote; Ansgar W. Lohse; Marianna Alunni-Fabbroni; Jens Ricke; Najib Ben Khaled; Matthias Pinter; Bernhard Scheiner; Samuel Huber; Johann von Felden; Ignazio Piseddu; Kornelius Schulze;

Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma Louisa Stern; Constantin Schmidt; Lorenz Kocheise; Vincent Joerg; Christian Casar; Aurélie Walter; Joost P.H. Drenth; Maria Papp; Nikolaos K. Gatselis; Kalliopi Zachou; Matthias Pinter; Bernhard Scheiner; Arndt Vogel; Martha M. Kirstein; Fabian Finkelmeier; Oliver Waidmann; Arndt Weinmann; Piotr Milkiewicz; Douglas Thorburn; Neil Halliday; Ana Lleo; Samuel Huber; George N. Dalekos; Ansgar W. Lohse; Henning Wege; Johann von Felden; Kornelius Schulze;